Valuation: GI Innovation, Inc.

Market Cap 623B 406M 356M 328M 308M 577M 38.34B 589M 3.95B 1.53B 18.95B 1.53B 1.49B 65.71B P/E 2024
-6.04x
P/E 2025 -29.2x
Enterprise Value 589B 384M 337M 310M 290M 545M 36.21B 556M 3.73B 1.44B 17.9B 1.44B 1.41B 62.06B EV / Sales 2024
15,970x
EV / Sales 2025 187x
Free-Float
93.25%
Yield 2024 *
-
Yield 2025 -
1 day-7.53%
1 week-16.02%
Current month-33.01%
1 month-35.25%
3 months-33.92%
6 months-46.05%
Current year-45.01%
1 week 9,470
Extreme 9470
12,130
1 month 9,470
Extreme 9470
15,600
Current year 9,470
Extreme 9470
18,830
1 year 9,470
Extreme 9470
22,600
3 years 6,809.09
Extreme 6809.0909
24,900
5 years 6,809.09
Extreme 6809.0909
24,900
10 years 6,809.09
Extreme 6809.0909
24,900
Manager TitleAgeSince
Chief Executive Officer 58 02/07/2025
Chief Executive Officer 54 16/06/2021
Director of Finance/CFO - 01/09/2024
Director TitleAgeSince
Director/Board Member 54 16/06/2021
Director/Board Member 58 01/07/2017
Director/Board Member 63 01/03/2022
Date Insider Type Main position Quantity % Market Cap.
01-20Fiscal year 14 0.0000%
01-20Expiration 330 0.0005%
01-20Expiration 1 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-7.53%-16.02%-55.40%+5.38% 406M
-0.48%+7.20%-5.65%+3.69% 46.2B
+2.19%+11.71%+393.31%+609.31% 38.71B
+2.53%+13.93%+21.38%-10.96% 31.9B
+1.65%+3.61%+16.04%+55.24% 31.12B
-4.16%-2.58%+8.94%+26.14% 23.77B
-0.32%+12.96% - - 16.2B
+1.37%+14.53%+69.64%+136.34% 15.05B
+1.00%+10.30%+13.31%+23.36% 13.74B
+3.63%+9.53%+103.97%+106.25% 13.42B
Average -0.01%+6.77%+62.84%+106.08% 23.05B
Weighted average by Cap. +0.74%+8.67%+88.47%+137.87%

Financials

2024 2025
Net sales 24.28M 15.83K 13.88K 12.8K 11.98K 22.46K 1.49M 22.93K 154K 59.51K 738K 59.45K 58.15K 2.56M 5.84B 3.81M 3.34M 3.08M 2.88M 5.4M 359M 5.51M 36.98M 14.31M 177M 14.29M 13.98M 615M
Net income -58.78B -38.33M -33.61M -30.98M -29M -54.38M -3.62B -55.51M -372M -144M -1.79B -144M -141M -6.2B -35.13B -22.91M -20.09M -18.52M -17.33M -32.51M -2.16B -33.18M -223M -86.11M -1.07B -86.03M -84.15M -3.7B
Net Debt -3.44B -2.24M -1.97M -1.81M -1.7M -3.18M -212M -3.25M -21.79M -8.43M -105M -8.42M -8.24M -363M -34.63B -22.58M -19.8M -18.25M -17.08M -32.04M -2.13B -32.7M -219M -84.87M -1.05B -84.78M -82.93M -3.65B
Logo GI Innovation, Inc.
GI Innovation Inc is a Korea-based company engaged in the research and development of next-generation immunotherapies based on fusion proteins. The Company is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.
Employees
-
Date Price Change Volume
26/06/26 ₩9,700.00 -7.53% 614,534
25/06/26 ₩10,490.00 -10.80% 1,047,625
24/06/26 ₩11,760.00 +4.07% 405,638
23/06/26 ₩11,300.00 -0.44% 496,313
22/06/26 ₩11,350.00 -1.73% 593,567
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
  1. Stock Market
  2. Stocks
  3. A358570 Stock